Sesames mission is to make affordable, high-quality health care accessible to all, regardless of insurance status
approximately 25% of all available drugs)
Whilst some gastrointestinal changes are expected with GLP-1 receptor agonists, ongoing diarrhoea, constipation, or other concerning symptoms may require investigation or management strategies
Food and Drug Administration The agency has issued warning letters to stop the distribution of illegally marketed semaglutide, saying the drugs may be counterfeit, which means they could contain the wrong ingredients, contain too little, too much or no active ingredient at all, or contain other harmful ingredients. In July, it said that it had received reports of dosing errors with compounded semaglutide injectable products, some of which landed patients in the hospital